These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 25687466)
1. High-throughput screening to identify inhibitors of lysine demethylases. Gale M; Yan Q Epigenomics; 2015; 7(1):57-65. PubMed ID: 25687466 [TBL] [Abstract][Full Text] [Related]
2. A High-Throughput Mass Spectrometry Assay Coupled with Redox Activity Testing Reduces Artifacts and False Positives in Lysine Demethylase Screening. Wigle TJ; Swinger KK; Campbell JE; Scholle MD; Sherrill J; Admirand EA; Boriack-Sjodin PA; Kuntz KW; Chesworth R; Moyer MP; Scott MP; Copeland RA J Biomol Screen; 2015 Jul; 20(6):810-20. PubMed ID: 25755264 [TBL] [Abstract][Full Text] [Related]
3. Screening for lysine-specific demethylase-1 inhibitors using a label-free high-throughput mass spectrometry assay. Plant M; Dineen T; Cheng A; Long AM; Chen H; Morgenstern KA Anal Biochem; 2011 Dec; 419(2):217-27. PubMed ID: 21855527 [TBL] [Abstract][Full Text] [Related]
4. High-throughput TR-FRET assays for identifying inhibitors of LSD1 and JMJD2C histone lysine demethylases. Yu V; Fisch T; Long AM; Tang J; Lee JH; Hierl M; Chen H; Yakowec P; Schwandner R; Emkey R J Biomol Screen; 2012 Jan; 17(1):27-38. PubMed ID: 21859682 [TBL] [Abstract][Full Text] [Related]
7. Recent Progress in Histone Demethylase Inhibitors. McAllister TE; England KS; Hopkinson RJ; Brennan PE; Kawamura A; Schofield CJ J Med Chem; 2016 Feb; 59(4):1308-29. PubMed ID: 26710088 [TBL] [Abstract][Full Text] [Related]
8. A protocol for high-throughput screening of histone lysine demethylase 4 inhibitors using TR-FRET assay. Wu Q; Lin W; Li ZM; Rankovic Z; White SW; Chen T; Yang J STAR Protoc; 2021 Sep; 2(3):100702. PubMed ID: 34485934 [TBL] [Abstract][Full Text] [Related]
9. Lysine Demethylation in Pathogenesis. Cao J; Yan Q Adv Exp Med Biol; 2023; 1433():1-14. PubMed ID: 37751133 [TBL] [Abstract][Full Text] [Related]
10. Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities. Rotili D; Tomassi S; Conte M; Benedetti R; Tortorici M; Ciossani G; Valente S; Marrocco B; Labella D; Novellino E; Mattevi A; Altucci L; Tumber A; Yapp C; King ON; Hopkinson RJ; Kawamura A; Schofield CJ; Mai A J Med Chem; 2014 Jan; 57(1):42-55. PubMed ID: 24325601 [TBL] [Abstract][Full Text] [Related]
11. Enabling lead discovery for histone lysine demethylases by high-throughput RapidFire mass spectrometry. Hutchinson SE; Leveridge MV; Heathcote ML; Francis P; Williams L; Gee M; Munoz-Muriedas J; Leavens B; Shillings A; Jones E; Homes P; Baddeley S; Chung CW; Bridges A; Argyrou A J Biomol Screen; 2012 Jan; 17(1):39-48. PubMed ID: 21859681 [TBL] [Abstract][Full Text] [Related]
12. An Overview on Screening Methods for Lysine Specific Demethylase 1 (LSD1) Inhibitors. Zheng YC; Chang J; Zhang T; Suo FZ; Chen XB; Liu Y; Zhao B; Yu B; Liu HM Curr Med Chem; 2017; 24(23):2496-2504. PubMed ID: 28486922 [TBL] [Abstract][Full Text] [Related]
13. Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4. Gauthier N; Caron M; Pedro L; Arcand M; Blouin J; Labonté A; Normand C; Paquet V; Rodenbrock A; Roy M; Rouleau N; Beaudet L; Padrós J; Rodriguez-Suarez R J Biomol Screen; 2012 Jan; 17(1):49-58. PubMed ID: 21940714 [TBL] [Abstract][Full Text] [Related]
15. A scintillation proximity assay for histone demethylases. Yu W; Eram MS; Hajian T; Szykowska A; Burgess-Brown N; Vedadi M; Brown PJ Anal Biochem; 2014 Oct; 463():54-60. PubMed ID: 25010373 [TBL] [Abstract][Full Text] [Related]
16. Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 1: High-Throughput Screening and Preliminary Exploration. Sartori L; Mercurio C; Amigoni F; Cappa A; Fagá G; Fattori R; Legnaghi E; Ciossani G; Mattevi A; Meroni G; Moretti L; Cecatiello V; Pasqualato S; Romussi A; Thaler F; Trifiró P; Villa M; Vultaggio S; Botrugno OA; Dessanti P; Minucci S; Zagarrí E; Carettoni D; Iuzzolino L; Varasi M; Vianello P J Med Chem; 2017 Mar; 60(5):1673-1692. PubMed ID: 28186755 [TBL] [Abstract][Full Text] [Related]
17. A sensitive, homogeneous, and high-throughput assay for lysine-specific histone demethylases at the H3K4 site. Wang C; Caron M; Burdick D; Kang Z; Auld D; Hill WA; Padrós J; Zhang JH Assay Drug Dev Technol; 2012 Apr; 10(2):179-86. PubMed ID: 22192306 [TBL] [Abstract][Full Text] [Related]
18. Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present). He X; Zhang H; Zhang Y; Ye Y; Wang S; Bai R; Xie T; Ye XY Eur J Med Chem; 2022 Mar; 231():114143. PubMed ID: 35101649 [TBL] [Abstract][Full Text] [Related]
19. Identification of Novel Selective Lysine-Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore-Based Virtual Screening Combined with Docking. Zhou C; Kang D; Xu Y; Zhang L; Zha X Chem Biol Drug Des; 2015 Jun; 85(6):659-71. PubMed ID: 25346381 [TBL] [Abstract][Full Text] [Related]
20. Histone Lysine Demethylase Inhibitors. Jambhekar A; Anastas JN; Shi Y Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 28049654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]